We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

28 hedge funds and large institutions have $6.54M invested in Microbot Medical in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more capital invested

Capital invested by funds: $3.25M → $6.54M (+$3.29M)

2.05% less ownership

Funds ownership: 14.24% → 12.19% (-2.1%)

10% less funds holding

Funds holding: 31 → 28 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
5
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$349K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.35K
3
KPW
Kore Private Wealth
New York
+$1.32K
4
AG
Advisor Group
Arizona
+$1.17K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$6

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$74.9K
2
SM
Sabby Management
Florida
-$43K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$29.3K
4
UBS Group
UBS Group
Switzerland
-$11.8K
5
GI
Gradient Investments
Minnesota
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.92M -$74.9K -12,774 -6%
BlackRock
2
BlackRock
New York
$1.86M -$563 -96 -0.1%
SM
3
Sabby Management
Florida
$773K -$43K -7,333 -9%
VF
4
Virtu Financial
New York
$606K +$349K +59,598 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$470K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$426K +$1.35K +231 +0.6%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$268K +$6 +1 +0%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$135K – – –
Morgan Stanley
9
Morgan Stanley
New York
$42K -$1.68K -286 -7%
SPIA
10
Steward Partners Investment Advisory
New York
$30K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$6K -$569 -97 -14%
Wells Fargo
12
Wells Fargo
California
$2K +$6 +1 +0.5%
AG
13
Advisor Group
Arizona
$2K +$1.17K +200 +10,000%
KPW
14
Kore Private Wealth
New York
$2K +$1.32K +225 New
FDCDDQ
15
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41 – – –
RE
16
RBC Europe
United Kingdom
$10 – – –
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
– -$29.3K -5,000 -100%
UBS Group
18
UBS Group
Switzerland
– -$11.8K -2,009 -100%
GI
19
Gradient Investments
Minnesota
– -$11K -2,000 Closed
Victory Capital Management
20
Victory Capital Management
Texas
– -$3K -659 Closed
AIC
21
Ameritas Investment Company
Nebraska
– -$1K -186 Closed
Barclays
22
Barclays
United Kingdom
– -$47 -8 -89%
Bank of America
23
Bank of America
North Carolina
– -$6 -1 -20%
Citigroup
24
Citigroup
New York
– -$6 -1 -33%
LTFS
25
Ladenburg Thalmann Financial Services
Florida
– +$6 +1 +17%
1
2

MBOT Hedge Fund Activity: Q4 2019 in Review

28 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2019, worth a combined $6.54M — up 101% from $3.25M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MBOT and 3 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 5 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $349K. The largest seller was Renaissance Technologies, cutting an estimated $74.9K.

  • 28 institutional investors held Microbot Medical (MBOT) as of Q4 2019, down from 31 in Q3 2019.
  • Funds reported $6.54M of Microbot Medical stock for Q4 2019, up 101% quarter-over-quarter.
  • 3 funds opened new Microbot Medical positions in Q4 2019 and 6 closed out, a net change of -3 holders.
  • The largest Microbot Medical buyer in Q4 2019 was Virtu Financial, an estimated $349K added.
  • The largest Microbot Medical seller in Q4 2019 was Renaissance Technologies, an estimated $74.9K sold.

Based on aggregated 13F filings for Q4 2019.